Daisuke Kotani

4.1k citations
112 papers · 2.0k · 1 hit paper · h-index 19

Impact in

  • Oncology top 2%
    • Cancer Immunotherapy and Biomarkers
    • Colorectal Cancer Treatments and Studies
    • Pancreatic and Hepatic Oncology Research
    • Gastrointestinal Tumor Research and Treatment

Papers in

    • Colorectal Cancer Treatments and Studies 60
    • Cancer Immunotherapy and Biomarkers 22
    • Colorectal Cancer Surgical Treatments 17
    • Gastric Cancer Management and Outcomes 37
    • Lung Cancer Treatments and Mutations 15

Daisuke Kotani

100 papers receiving 2.0k citations

Daisuke Kotani's Hit Papers

Regorafenib Plus Nivolumab in Patients With Advanced Gastric or Colorectal Cancer: An Open-Label, Dose-Escalation, and Dose-Expansion Phase Ib Trial (REGONIVO, EPOC1603) 2020 · 567 citations
5670+2+4Years since publication100200300400500

Peers

Daisuke Kotani
Comparison fields: 5 of 76
  • Oncology 1.5k
  • Gastroenterology 177
  • Pathology and Forensic Medicine 558
  • Cancer Research 376
  • Pulmonary and Respiratory Medicine 729
Replace Yasutoshi Kuboki with:
Yasutoshi Kuboki Japan
Dakeun Lee South Korea
Shota Fukuoka Japan
Naoki Takahashi Japan
Christine Lagorce France
Georgy M. Manikhas Russia
Marisol Huerta Spain
Orianne Colussi France
Takamitsu Kanazawa Japan
Hironori Shiozaki Japan
Daisuke Kotani relative to Yasutoshi Kuboki Japan Yasutoshi Kuboki's profile →
Citations per field
00.5×1.5×
Yasutoshi Kuboki · 1×
Citations per year

Countries citing papers authored by Daisuke Kotani

Since Specialization
Citations

This map shows the geographic impact of Daisuke Kotani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daisuke Kotani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daisuke Kotani more than expected).

Fields of papers citing papers by Daisuke Kotani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daisuke Kotani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daisuke Kotani. The network helps show where Daisuke Kotani may publish in the future.

Co-authors

The 25 scholars most cited alongside Daisuke Kotani, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Daisuke Kotani Line = papers co-authored together Daisuke Kotani links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 112 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Regorafenib Plus Nivolumab in Patients With Advanced Gastric or Colorectal Cancer: An Open-Label, Dose-Escalation, and Dose-Expansion Phase Ib Trial (REGONIVO, EPOC1603)
Hit paper breakdown →
2020567
2 2018154
3 2019112
4 202192
5 201985
6 202383
7 202176
8 201959
9 201657
10 202054
11 202047
12 202141
13 202140
14 202240
15 202039
16 202030
17 201929
18 202126
19 202121
20 201516

About Daisuke Kotani

Daisuke Kotani is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Surgery, Cancer Research and Pathology and Forensic Medicine, having authored 112 papers that have together received 2.0k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (60 papers), Gastric Cancer Management and Outcomes (37 papers), Cancer Genomics and Diagnostics (26 papers), Genetic factors in colorectal cancer (25 papers), Cancer Immunotherapy and Biomarkers (22 papers), Esophageal Cancer Research and Treatment (21 papers), Colorectal Cancer Surgical Treatments (17 papers) and Lung Cancer Treatments and Mutations (15 papers). The work is most often cited by research in Oncology (1.5k citations), Gastroenterology (177 citations), Pathology and Forensic Medicine (558 citations), Cancer Research (376 citations) and Pulmonary and Respiratory Medicine (729 citations). Daisuke Kotani has collaborated with scholars based in Japan, United States and Taiwan. Frequent co-authors include Kohei Shitara, Akihito Kawazoe, Takashi Kojima, Takeshi Kuwata, Takayuki Yoshino, Hiroyoshi Nishikawa, Yosuke Togashi, Masashi Wakabayashi, Akihiro Sato and Yoshiaki Nakamura. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Clinical Cancer Research, BMC Cancer and Therapeutic Advances in Medical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact